The scientific publications from France in the top 10% most-cited papers in Pulmonary and Respiratory Medicine are forecasted to gradually increase from 2024 to 2028, with a steady annual rise. Given 2023's actual data at a baseline, this suggests consistent, moderate growth in the realm of impactful papers from 2024 onward. The year-on-year growth demonstrates incremental increases, with each year witnessing a slight rise in the number of publications, leading to a cumulative effect of expanding the country's influence in this medical domain.

Future trends to watch for:

The impact of new research technologies and collaborations on publication volumes.
Policy shifts in France affecting research funding and international collaborations.
Emergence of new diseases which might drive increased research output.